EMAS position statement: Thyroid disease and menopause

Abstract

Introduction

Thyroid diseases are common in women in their late reproductive years; therefore, thyroid disease and menopause may co-exist. Both conditions may present with a wide range of symptoms, leading to diagnostic challenges and delayed diagnosis.

Aim

To construct the first European Menopause and Andropause Society (EMAS) statement on thyroid diseases and menopause.

Materials and methods

Literature review and consensus of expert opinion (EMAS executive board members/experts on menopause and thyroid disease).

Summary recommendations

This position paper highlights the diagnostic and therapeutic dilemmas in managing women with thyroid disease during the menopausal transition, aiming to increase healthcare professionals' awareness of thyroid disorders and menopause-related symptoms. Clinical decisions regarding the treatment of both conditions should be made with caution and attention to the specific characteristics of this age group while adopting a personalized patient approach. The latter must include the family history, involvement of the woman in the decision-making, and respect for her preferences, to achieve overall well-being.